Given risks to ADT, do you use it for cytoreduction in low risk and favorable intermediate risk patients prior to brachytherapy or SBRT?  

ADT for purely cytoreduction has increasingly fallen out of favor with variable guidelines discouraging the use of ADT solely for this purpose. This is in part because low-risk men should be offered active surveillance now, and unfavorable intermediate and high-risk men generally should be offered A...